All Stories

  1. Assessing ocular dominance: rethinking the current paradigm
  2. Reversal of Pharmacologically Induced Mydriasis with Phentolamine Ophthalmic Solution
  3. Neurotrophic keratopathy: An updated understanding
  4. A randomized phase 2 clinical trial of phentolamine mesylate eye drops in patients with severe night vision disturbances
  5. Expert consensus on the identification, diagnosis, and treatment of neurotrophic keratopathy
  6. Phentolamine Eye Drops Reverse Pharmacologically Induced Mydriasis in a Randomized Phase 2b Trial
  7. Phentolamine Mesylate Ophthalmic Solution Provides Lasting Pupil Modulation and Improves Near Visual Acuity in Presbyopic Glaucoma Patients in a Randomized Phase 2b Clinical Trial
  8. <p>Objective Quantification of Image Quality and Optical Scatter Before and After Nd:YAG Capsulotomy Using a Double-Pass Technique</p>
  9. Perspective on Systematic Medical Literature Reviews and Meta-Analyses
  10. <p>Direct and Indirect Costs of Infectious Conjunctivitis in a Commercially Insured Population in the United States</p>
  11. ISOPT Clinical Hot Topic Panel Discussion on Cornea Anterior Segment Disease
  12. Randomized, Controlled, Phase 2 Trial of Povidone-Iodine/Dexamethasone Ophthalmic Suspension for Treatment of Adenoviral Conjunctivitis
  13. A randomized controlled trial of povidone-iodine/dexamethasone ophthalmic suspension for acute viral conjunctivitis
  14. Longitudinal changes in dry eye symptoms and signs following lifitegrast therapy and relationship to tear osmolarity
  15. Reply
  16. Randomized, Controlled, Phase 2 Trial of Povidone-Iodine/Dexamethasone Ophthalmic Suspension for Treatment of Adenoviral Conjunctivitis
  17. Evaluation of the small-aperture intracorneal inlay: Three-year results from the cohort of the U.S. Food and Drug Administration clinical trial
  18. Long-term safety follow-up of an anterior chamber angle-supported phakic intraocular lens
  19. TFOS DEWS II iatrogenic report
  20. Accommodating Intraocular Lenses
  21. Benefits and barriers of accommodating intraocular lenses
  22. Contrast Sensitivity in Patients With Emmetropic Presbyopia Before and After Small-Aperture Inlay Implantation
  23. Reply
  24. Reply
  25. Progressively Increased Variation in Tear Osmolarity Mirrors Dry Eye Severity
  26. Comparison of Contrast Sensitivity and Through Focus in Small-Aperture Inlay, Accommodating Intraocular Lens, or Multifocal Intraocular Lens Subjects
  27. Safety and effectiveness of a new toric presbyopia-correcting posterior chamber silicone intraocular lens
  28. A Prospective Randomized Clinical Evaluation of 3 Presbyopia-Correcting Intraocular Lenses After Cataract Extraction
  29. Rethinking Dry Eye Disease: A Perspective on Clinical Implications
  30. The Value of Tear Osmolarity as a Metric in Evaluating the Response to Dry Eye Therapy in the Clinic and in Clinical Trials
  31. Corneal inlays for presbyopia correction
  32. Comparing visual function of accommodating IOLs versus mini-monovision with a nonaccommodating monofocal IOL
  33. Evaluation of Tear Osmolarity in Non-Sjögren and Sjögren Syndrome Dry Eye Patients With the TearLab System
  34. Acute Retinal Necrosis Syndrome
  35. Small-aperture contact lenses for presbyopia
  36. Clinical Utility of Objective Tests for Dry Eye Disease
  37. Comparison of Through-Focus Image Sharpness Across Five Presbyopia-Correcting Intraocular Lenses
  38. Tear Osmolarity in the Diagnosis and Management of Dry Eye Disease
  39. March consultation #4
  40. An Objective Approach to Dry Eye Disease Severity
  41. Comparing pupil-dependent image quality across presbyopia-correcting intraocular lenses
  42. February consultation #10
  43. Postoperative changes in intraocular pressure and corneal biomechanical metrics
  44. Novel Objective Method for Comparing Ablation Centration With and Without Pupil Tracking Following Myopic Laser In Situ Keratomileusis Using the Bausch & Lomb Technolas 217A
  45. Comparison of contrast sensitivity, depth of field and ocular wavefront aberrations in eyes with an IOL with zero versus positive spherical aberration
  46. Maximizing Satisfaction with Presbyopia-Correcting Intraocular Lenses: The Missing Links
  47. Biometry and intraocular lens power calculation
  48. Visual Performance of Patients with Bilateral vs Combination Crystalens, ReZoom, and ReSTOR Intraocular Lens Implants
  49. Comparative performance of the Zyoptix XP and Hansatome zero-compression microkeratomes
  50. Reply: Determining corneal power using Orbscan II videokeratography for IOL calculation after excimer laser surgery for myopia
  51. Determining corneal power using Orbscan II videokeratography for intraocular lens calculation after excimer laser surgery for myopia
  52. Changes in Corneal Biomechanics and Intraocular Pressure Following LASIK Using Static, Dynamic, and Noncontact Tonometry
  53. Development of late-onset subepithelial corneal haze after laser-assisted subepithelial keratectomy with prophylactic intraoperative mitomycin-C
  54. Ocular Herpes Simplex: Changing Epidemiology, Emerging Disease Patterns, and the Potential of Vaccine Prevention and Therapy
  55. Acute Retinal Necrosis Syndrome
  56. Is There A Role for Neurotrophin Treatment of the Ocular Surface Following Laser In Situ Keratomileusis (LASIK)?
  57. Factors Predictive of LASIK Flap Thickness With the Hansatome Zero Compression Microkeratome
  58. Reply
  59. Subepithelial scarring after laser-assisted subepithelial keratectomy
  60. Optical performance of 3 intraocular lens designs in the presence of decentration
  61. Making sense out of wavefront sensing
  62. Topographic and biomechanical differences between hyperopic and myopic laser in situ keratomileusis
  63. Mitomycin C and Haze
  64. Treatment of dense subepithelial corneal haze after laser-assisted subepithelial keratectomy
  65. The effect of punctal occlusion on wavefront aberrations in dry eye patients after laser in situ keratomileusis
  66. Retained contact lens for more than 10 years in a laser in situ keratomileusis patient
  67. Ocular complications of smallpox vaccination
  68. Intraocular lens calculations in patients with corneal scarring and irregular astigmatism
  69. IMPLANTATION OF SCLERAL EXPANSION BAND SEGMENTS FOR THE TREATMENT OF PRESBYOPIA
  70. Human Corneal Endothelial Cell Expression of Na+, K+–Adenosine Triphosphatase Isoforms
  71. Schachar's Theory of the Mechanisms of Accommodation
  72. Correlation of visual and refractive outcomes between eyes after Same-session bilateral laser in situ keratomileusis surgery
  73. Microdissection combined with the polymerase chain reaction to identify potentiating viral co-infection in patients with HIV/AIDS with ocular infection
  74. Implantation of scleral expansion band segments for the treatment of presbyopia11A complete list of the participants in the Scleral Expansion Band for Presbyopia Study Group can be found at the end of this article.
  75. Therapeutic vaccination with vhs− herpes simplex virus reduces the severity of recurrent herpetic stromal keratitis in mice
  76. Confocal microscopic findings in a case of delayed-onset bilateral diffuse lamellar keratitis after laser in situ keratomileusis
  77. CD4+ and CD8+ cells are key participants in the development of recurrent herpetic stromal keratitis in mice
  78. Therapeutic Immunization with a Virion Host Shutoff-Defective, Replication-Incompetent Herpes Simplex Virus Type 1 Strain Limits Recurrent Herpetic Ocular Infection
  79. InternetAdvance: accelerated internet publication of articles and reports at ajo.com
  80. Astigmatic changes after excimer laser refractive surgery
  81. Comparison of photorefractive keratectomy, astigmatic PRK, laser in situ keratomileusis, and astigmatic LASIK in the treatment of myopia
  82. Management of the corneal flap in laser in situ keratomileusis after previous radial keratotomy
  83. Disinfection of Goldmann tonometers after contamination with hepatitis C virus
  84. Cytokine expression in murine corneas during recurrent herpetic stromal keratitis
  85. Maximizing surgeon safety during excimer laser photorefractive procedures
  86. Editor reply
  87. Repopulation of denuded murine Descemet's membrane with life-extended murine corneal endothelial cells as a model for corneal cell transplantation
  88. CD4+ T CELLS ARE CRITICAL FOR CORNEAL, BUT NOT SKIN, ALLOGRAFT REJECTION1
  89. Stimulation of quiescent corneal endothelial cells by direct delivery of the SV40 large T-antigen protein
  90. Stimulation of quiescent corneal endothelial cells by direct delivery of the SV40 large T-antigen protein
  91. Comparative corneal topography and refractive variables in monozygotic and dizygotic twins
  92. Corneal iron deposits after laser in situ keratomileusis
  93. Discussion
  94. Human cytomegalovirus infection in a retinoblastoma cell line in vitro
  95. Improved impression cytology techniques for the immunopathological diagnosis of superficial viral infections
  96. Neural network computer program to determine photorefractive keratectomy nomograms
  97. Reproduction of antiviral effect in an in vivo model of human cytomegalovirus retinal infection
  98. Screening of Myopic Photorefractive Keratectomy in Eye Bank Eyes by Computerized Videokeratography
  99. CONTROL POINTS REGULATING EPITHELIAL HYPERPLASIA
  100. Efficacy and safety of the proTek (Vifilcon A) therapeutic soft contact lens after photorefractive keratectomy
  101. Effect of PRK on intraocular pressure measurements and on keratometry
  102. Postexposure vaccination with a virion host shutoff defective mutant reduces UV-B radiation-induced ocular herpes simplex virus shedding in mice
  103. Results of Phase III Excimer Laser Photorefractive Keratectomy for Myopia
  104. In Vitro and In Vivo Effects of Polyhexamethylene Biguanide Against Herpes Simplex Virus Infection
  105. An In Vivo Model of Human Cytomegalovirus Retinal Infection
  106. Efficacy of a Recombinant Glycoprotein D Subunit Vaccine on the Development of Primary and Recurrent Ocular Infection with Herpes Simplex Virus Type 1 in Mice
  107. Corneal Topography of Excimer Laser Photorefractive Keratectomy Using a 6-mm Beam Diameter
  108. Future shock: the long term consequences of refractive surgery
  109. Lack of Diurnal Variation in Vision, Refraction, or Keratometry After Excimer Laser Photorefractive Keratectomy
  110. A Critical Evaluation of Hepatitis C Testing of Cadaveric Corneal Donors
  111. SCREENING POTENTIAL CORNEAL DONORS FOR HIV-1 BY POLYMERASE CHAIN REACTION AND A COLORIMETRIC MICROWELL HYBRIDIZATION ASSAY
  112. The Potential Impact of the Varicella Vaccine and New Antivirals on Ocular Disease Related to Varicella-zoster Virus
  113. CD95 ligand (FasL)-induced apoptosis is necessary for corneal allograft survival.
  114. Retreatment of Decentered Excimer Photorefractive Keratectomy Ablations
  115. Differential effects of HSV-1 and HCMV infection on adhesion molecule expression on human corneal keratocytes
  116. Screening Potential Corneal Donors for HIV-1 by Polymerase Chain Reaction and a Colorimetric Microwell Hybridization Assay
  117. A Comparison of Recurrent and Primary Herpes Simplex Keratitis in NIH Inbred Mice
  118. A UNIQUE CASE OF FUCHS?? SUPERFICIAL MARGINAL KERATITIS: MANAGEMENT VIA CORNEOSCLERAL LAMELLAR PATCH GRAFT
  119. Corneal optical irregularity after excimer laser photorefractive keratectomy
  120. Cystic Hydrops and Spontaneous Perforation in Fuchs' Superficial Marginal Keratitis
  121. Air Bag-related Corneal Rupture After Radial Keratotomy
  122. AIDS-related optic neuropathy: a histological, virological and ultrastructural study
  123. Corneal Topography of Phase III Excimer Laser Photorefractive Keratectomy
  124. Corneal Topography of Phase III Excimer Laser Photorefractive Keratectomy
  125. Topical Interferon Alpha-2A Treatment of Herpes Simplex Keratitis Resistant to Multiple Antiviral Medications in an Immunosuppressed Patient
  126. Anterior Segment Manifestations of Acquired Immunodeficiency Syndrome
  127. AIRBAG-ASSOCIATED CORNEAL RUPTURE TWO YEARS AFTER RADIAL KERATOTOMY
  128. Screening Corneas for Human Immunodeficiency Virus Type 1 Proviral DNA by Polymerase Chain Reaction
  129. Poor Correlation Between Reactive Syphilis Serology and Human Immunodeficiency Virus Testing Among Potential Cornea Donors
  130. ATTITUDES OF SUCCESSFUL CONTACT LENS WEARERS TOWARD REFRACTIVE SURGERY
  131. Sequence changes in the pilus subunit lead to variation of Neisseria gonorrhoeae to human tissue
  132. A structural and functional comparison of the latency-associated transcript promoters of herpes simplex virus type 1 strains KOS and McKrae
  133. Sequence changes in the pilus subunit lead to tropism variation of Neisseria gonorrhoeae to human tissue
  134. The role of nerve growth factor in modulating herpes simplex virus reactivation in vivo
  135. Vaccinia Keratouveitis Manifesting as a Masquerade Syndrome
  136. Spontaneous Resolution of an Extensive Detachment of Descemet's Membrane Following Phacoemulsification
  137. Lack of Evidence for Hepatitis C Virus in Corneas of Seropositive Cadavers
  138. Detection of Cellular Adhesion Molecules in Inflamed Human Corneas
  139. REACTIVE SYPHILIS SEROLOGY IS A POOR MARKER FOR HIV INFECTION AMONG POTENTIAL CORNEAL DONORS IN THE U.S
  140. Comparative Diagnosis of Neonatal Chlamydial Conjunctivitis by Polymerase Chain Reaction and McCoy Cell Culture
  141. In vivo characterization of site-directed mutations in the promoter of the herpes simplex virus type 1 latency-associated transcripts
  142. Immunocytologic Findings in a Case of Vogt-Koyanagi-Harada Syndrome
  143. The Use of Polymerase Chain Reaction for the Detection of Chlamydial Keratoconjunctivitis
  144. Divergent Approaches to the Management of Corneal Ulcers
  145. Corneal Endothelial Toxicity of DexSol Corneal Storage Medium Supplemented With Povidone-Iodine
  146. Reactivation of Latent Herpes Simplex Virus by Excimer Laser Photokeratectomy
  147. New Developments in Serologic Screening of Corneal Donors for HIV-1 and Hepatitis B Virus Infections
  148. Herpesvirus Antibody Levels in the Etiologic Diagnosis of the Acute Retinal Necrosis Syndrome
  149. Immunopathologic Features of Retinal Lesions in Multiple Sclerosis
  150. Concurrent Chlamydial and Acanthamoeba Keratoconjunctivitis
  151. Screening Corneal Donors for Transmissible Disease
  152. Antimicrobial Efficacy and Corneal Endothelial Toxicity of DexSol Corneal Storage Medium Supplemented with Vancomycin
  153. Herpes simplex keratitis: Role of viral infection versus immune response
  154. Detection of HLA Antigens in Human Epikeratophakia Lenticules
  155. External ocular herpesvirus infections in immunodeficiency
  156. Dual Infection of Retina with Human Immunodeficiency Virus Type 1 and Cytomegalovirus
  157. Mononuclear Cell Phenotypes and Immunoglobulin Gene Rearrangements in Lacrimal Gland Biopsies from Patients with Sjögren's Syndrome
  158. 90122536 Estrogen and progesterone receptors and human conjunctiva
  159. Recurrent Acanthamoeba Keratitis Following Penetrating Keratoplasty
  160. Epidermal Growth Factor in Human Aqueous Humor
  161. Estrogen and Progesterone Receptors and Human Conjunctiva
  162. Sandwich enzyme immunoassay and latex agglutination test for herpes simplex virus keratitis
  163. Epstein-Barr Virus infection and Immunologic Dysfunction in Patients with Aqueous Tear Deficiency
  164. The Sensitivity of Neisseria gonorrhoeae, Chlamydia trachomatis, and Herpes Simplex Type II to Disinfection With Povidone-Iodine
  165. Cellular Immune Response to la Induction by Intraocular Gamma-Interferon
  166. Comparative Laboratory Diagnosis of Experimental Herpes Simplex Keratitis
  167. An Association Between Acute Retinal Necrosis Syndrome and HLA-DQw7 and Phenotype Bw62,DR4
  168. Epidemiology and Diagnosis of Acute Conjunctivitis at an Inner-city Hospital
  169. Congenital Idiopathic Corneal Endotheliopathy
  170. Disinfection of Goldmann Tonometers Against Human Immunodeficiency Virus Type 1
  171. Proliferative Vitreoretinopathy Membranes
  172. Dual Infection of Retina With Human Immunodeficiency Virus Type 1 and Cytomegalovirus
  173. The relationship of corneal Langerhans cells to herpes simplex antigens during dendritic keratitis
  174. The Risk of Cytomegalovirus Transmission by Penetrating Keratoplasty
  175. A viral etiology in Fuchs' corneal dystrophy
  176. Application of Immunologic Technology to the Diagnosis of Viral Infections of the Ocular Surface
  177. Herpes simplex virus Type 1 induces anterior chamber-associated immune deviation (ACAID) in mouse strains resistant to intraocular infection
  178. Serologic Markers After the Transplantation of Corneas from Donors Infected with Human Immunodeficiency Virus
  179. Pathologic Features of Cytomegalovirus Retinopathy after Treatment with the Antiviral Agent Ganciclovir
  180. Screening Cornea Donors for Antibodies Against Human Immunodeficiency Virus
  181. AIDS and Corneal Transplantation
  182. Application of Immunotechnology to the Diagnosis of Ocular Viral Infections
  183. Antiviral sensitivities of the acute retinal necrosis syndrome virus
  184. Class II induction of human corneal fibroblasts by cell-free supernatants from HSV stimulated lymphocytes
  185. Demonstration of Herpes Group Virus in Acute Retinal Necrosis Syndrome
  186. Acute Retinal Necrosis Syndrome Following Herpes Zoster Dermatitis
  187. HTLV-III ELISA testing of cadaveric sera to screen potential organ transplant donors
  188. HTLV-III ELISA Testing of Cadaveric Sera to Screen Potential Organ Transplant Donors
  189. Herpes simplex virus immediate-early protein ICP4 in murine models of latency
  190. Infectious Retinitis
  191. Varicella Zoster Virus is a Cause of the Acute Retinal Necrosis Syndrome
  192. External Diseases
  193. Detection of HLA Class I and II Antigens in Rejected Human Corneal Allografts
  194. The Impact of the AIDS Epidemic on Corneal Transplantation
  195. Acquired Immune Deficiency Syndrome
  196. Immunocytologic Localization of Herpes Simplex Type 1 Viral Antigens in Herpetic Retinitis and Encephalitis in an Adult
  197. Composition of cellular infiltrates in rejected human corneal allografts
  198. Skin Test With Varicella-Zoster Virus Antigen for Ophthalmic Herpes Zoster
  199. Concurrent Herpes Simplex and Cytomegalovirus, Retinitis and Encephalitis in the Acquired Immune Deficiency Syndrome (AIDS)
  200. Retinal Periphlebitis and Retinitis in Multiple Sclerosis
  201. Acquired Immune Deficiency Syndrome
  202. An Analysis of Retinal Cotton-Wool Spots and Cytomegalovirus Retinitis in the Acquired Immunodeficiency Syndrome
  203. A theory of virus-induced demyelination in the Landry-Guillain-Barr� syndrome
  204. Marek's disease: A natural model for the Landry-Guillain-Barr� syndrome
  205. The Humoral Immune Response in Rabbits Infected with Treponema pallidum
  206. Microassay for immunoglobulin G antibodies to Treponema pallidum with radioiodinated protein A from staphylococcus aureus: immunoglobulin G response in experimental syphilis in rabbits
  207. Voltage-sensitive potassium channels in Limulus ventral photoreceptors